Zinger Key Points
- Ericsson hares surged on first-quarter results and successful test of AI-native link adaptation.
- Eli Lilly jumped on strong Phase 3 diabetes drug trial results boosting investor confidence.
- Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On
These large-cap stocks were the best performers in the last week. Are they in your portfolio?
Trending Investment Opportunities
Advertisement
- ServiceTitan, Inc. TTAN stock jumped 22.55% after it announced a strategic partnership with Cobalt Service Partners to power 12 commercial access solutions brands with its business management software.
- Summit Therapeutics Inc. SMMT shares were up 22.13%.
- YPF Sociedad Anonima YPF shares increased 19.94% after HSBC analyst Liyanna Yang upgraded the stock from Reduce to Hold and raised the price forecast from $21 to $33.
- Eli Lilly And Co LLY stock rose 16.51% after the U.S. healthcare giant reported topline Phase 3 results from the ACHIEVE-1 trial of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
- MicroStrategy Incorporated MSTR shares grew 16.47% after the company hinted it might resume purchasing Bitcoin BTC/USD after a week-long pause.
- America Movil AMX stock upped 15.88% after HSBC analyst Madhvendra Singh upgraded the stock from Hold to Buy and raised its price forecast from $15.5 to $17.5.
- Ericsson ERIC shares upped 14.91% after the company reported first-quarter results. Additionally, the company and Bell Canada announced the successful test of AI-native link adaptation to boost network speed and efficiency.
- Insmed Incorporated INSM stock rose 12.10%.
- Diamondback Energy, Inc. FANG stock surged 11.76% after Truist Securities analyst Neal Dingmann raised its price forecast from $238 to $242 and maintained a Buy rating.
- Neurocrine Biosciences Inc NBIX shares increased 11.75% after some analysts upgraded the stock.
Photo by DCStockPhotography via Shutterstock
Loading...
Loading...
LLYEli Lilly and Co
$791.860.15%
Edge Rankings
Momentum
27.05
Growth
99.76
Quality
89.49
Value
3.67
Price Trend
Short
Medium
Long
MSTRStrategy
$433.302.74%
AMXAmerica Movil SAB de CV
$17.54-0.51%
ERICTelefonaktiebolaget L M Ericsson
$8.12-0.73%
FANGDiamondback Energy Inc
$144.330.91%
INSMInsmed Inc
$98.501.90%
NBIXNeurocrine Biosciences Inc
$133.46-1.08%
SMMTSummit Therapeutics Inc
$25.12-2.94%
TTANServiceTitan Inc
$106.96-3.59%
YPFYPF SA
$30.97-2.61%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.